CL2018003878A1 - Formulation comprising extract of crynodendron patagua and essential oil of satureja montana for the prevention and treatment of diseases caused by piscirickettsia salmonis in individuals of the genus Salmo. - Google Patents

Formulation comprising extract of crynodendron patagua and essential oil of satureja montana for the prevention and treatment of diseases caused by piscirickettsia salmonis in individuals of the genus Salmo.

Info

Publication number
CL2018003878A1
CL2018003878A1 CL2018003878A CL2018003878A CL2018003878A1 CL 2018003878 A1 CL2018003878 A1 CL 2018003878A1 CL 2018003878 A CL2018003878 A CL 2018003878A CL 2018003878 A CL2018003878 A CL 2018003878A CL 2018003878 A1 CL2018003878 A1 CL 2018003878A1
Authority
CL
Chile
Prior art keywords
patagua
crynodendron
individuals
formulation
prevention
Prior art date
Application number
CL2018003878A
Other languages
Spanish (es)
Inventor
Navarro Gustavo Emilio Zuñiga
Soto Ruben Rodrigo Vidal
Coloma Azuzena Gonzalez
Yeves María Fe Andres
Hernandez Carmen Elisa Diaz
Alquezar Jesus Burrillo
Rocha Juliana Navarro
Original Assignee
Univ De Santiago De Chile 50%
Consejo Superior De Investig Cientificas 30%
Centro De Investig Y Tecnologia Agroalimentaria De Aragon Cita 20%
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ De Santiago De Chile 50%, Consejo Superior De Investig Cientificas 30%, Centro De Investig Y Tecnologia Agroalimentaria De Aragon Cita 20% filed Critical Univ De Santiago De Chile 50%
Priority to CL2018003878A priority Critical patent/CL2018003878A1/en
Publication of CL2018003878A1 publication Critical patent/CL2018003878A1/en
Priority to ES201931162A priority patent/ES2769918B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Abstract

La presente invención se engloba en el sector de la acuicultura y se refiere a una formulación que comprende una mezcla de un extracto vegetal de la variedad de planta <em>Crynodendron patagua</em> y de aceite esencial de la variedad de planta <em>Satureja montana</em>, que se utiliza en la prevención y tratamiento de enfermedades causadas por la bacteria <em>Piscirickettsia salmonis</em> en individuos del género Salmo, y más preferentemente, en truchas y salmones.The present invention is encompassed in the aquaculture sector and refers to a formulation comprising a mixture of a plant extract of the plant variety <em> Crynodendron patagua </em> and essential oil of the plant variety <em > Satureja montana </em>, which is used in the prevention and treatment of diseases caused by the bacteria <em> Piscirickettsia salmonis </em> in individuals of the genus Salmo, and more preferably, in trout and salmon.

CL2018003878A 2018-12-28 2018-12-28 Formulation comprising extract of crynodendron patagua and essential oil of satureja montana for the prevention and treatment of diseases caused by piscirickettsia salmonis in individuals of the genus Salmo. CL2018003878A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CL2018003878A CL2018003878A1 (en) 2018-12-28 2018-12-28 Formulation comprising extract of crynodendron patagua and essential oil of satureja montana for the prevention and treatment of diseases caused by piscirickettsia salmonis in individuals of the genus Salmo.
ES201931162A ES2769918B2 (en) 2018-12-28 2019-12-27 Formulation comprising extract of Crinodendron patagua and essential oils of Satureja montana for the prevention and treatment of diseases caused by Piscirickettsia salmonis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2018003878A CL2018003878A1 (en) 2018-12-28 2018-12-28 Formulation comprising extract of crynodendron patagua and essential oil of satureja montana for the prevention and treatment of diseases caused by piscirickettsia salmonis in individuals of the genus Salmo.

Publications (1)

Publication Number Publication Date
CL2018003878A1 true CL2018003878A1 (en) 2019-05-17

Family

ID=66682759

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018003878A CL2018003878A1 (en) 2018-12-28 2018-12-28 Formulation comprising extract of crynodendron patagua and essential oil of satureja montana for the prevention and treatment of diseases caused by piscirickettsia salmonis in individuals of the genus Salmo.

Country Status (2)

Country Link
CL (1) CL2018003878A1 (en)
ES (1) ES2769918B2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20100454A1 (en) * 2010-03-26 2011-09-27 Ewos Innovation As Compound and composition for control of bacteria and viruses
RS54162B1 (en) * 2011-12-28 2015-12-31 Univerzitet U Beogradu Pharmaceutical composition based on the medicinal herbs for use in human and veterinary medicine
CL2015000876A1 (en) * 2015-04-08 2015-08-28 Maqui New Life S A Veterinary composition of seaweed extract with at least 5% of fucoidians and andrographis sp plant extract with at least 5% of andrographolides, useful in the control and prevention of infections caused by intracellular microorganisms in fish.
CL2018000674A1 (en) * 2018-03-13 2018-06-08 Univ Santiago Chile Natural antibacterial extracts of crynodendron patagua, aristotelia chilensis or mixtures thereof, grown in vitro, food additive for fish diet that includes them, food formulation for fish comprising said additive and its use in the treatment or prevention of bacterial infections, in especially, an infection with piscirickettsia salmonis, responsible for rickettsial salmon syndrome (srs).

Also Published As

Publication number Publication date
ES2769918B2 (en) 2021-10-15
ES2769918A1 (en) 2020-06-29

Similar Documents

Publication Publication Date Title
UY37563A (en) ISOLATED BACILLUS AND USES OF THE SAME
UY37561A (en) BACTERIAL CEPAS, COMPOSITIONS THAT INCLUDE THEM, PLANTS AND SEEDS TREATED WITH THESE AND RELATED METHODS
CO2018001115A2 (en) Compositions ingested by bees, procedures for using them to produce honey and honey produced in this way
CL2021001352A1 (en) Yeast-based compositions to improve the properties of the rhizosphere and the health of plants
CL2017000562A1 (en) Algae concentrated extract, its method of production and use in agriculture
CO7151524A2 (en) Enhanced antagonistic antibodies against growth-differentiation factor-8 and their uses
AR101961A1 (en) COMPOSITIONS THAT INCLUDE BACILLUS RECOMBINATING CELLS AND ANOTHER BIOLOGICAL CONTROL AGENT
BR112012022669A2 (en) immunogenic composition, method of treating or preventing infection or disease, use of an antigen, kit, methods for making an immunogenic composition and for improving a vaccine.
AR099679A1 (en) COMPOSITIONS FOR CONTROL OF WEEDS WITH SAFLUFENACIL, FLUMIOXAZIN, AND 2,4-D AND METHODS FOR USE
CL2021000005A1 (en) Substituted thiophenecarboxamides and analogs thereof
GT201400069A (en) PHARMACEUTICAL COMPOSITIONS
PE20151588A1 (en) VACCINE AGAINST DENGUE VIRUS
AR102780A1 (en) PHARMACEUTICAL COMPOSITIONS, THEIR PREPARATION AND THEIR USES
CL2019003572A1 (en) Low-dose brimonidine combinations and uses thereof.
UY31437A1 (en) MYCOPLASMA BOVIS VACCINE AND SAME USE METHODS
ECSP20016817A (en) SYSTEMS AND METHODS FOR THE CONTROL OF ACUTE HEPATOPANCREATIC NECROSIS DISEASE
CL2021002582A1 (en) Vaccines against porcine circovirus type 3 (pcv3), their production and uses
AR120057A1 (en) NEOANTIGENIC COMPOSITIONS AND THEIR USES
ECSP21072250A (en) COMPOSITIONS BASED ON COLLOIDAL SILVER AND METHODS OF USING THEM TO PREVENT AND CONTROL PLANT DISEASES
PE20160474A1 (en) SYSTEM AND PROCEDURE FOR THE EXTRACTION OF PALM OIL THROUGH FRACTURING, SHELLING AND DYNAMIC STERILIZATION OF FRESH FRUIT
AR111181A1 (en) METHODS AND COMPOSITIONS TO IMPROVE PLANT HEALTH AND / OR PLANT PERFORMANCE
CL2018003878A1 (en) Formulation comprising extract of crynodendron patagua and essential oil of satureja montana for the prevention and treatment of diseases caused by piscirickettsia salmonis in individuals of the genus Salmo.
AR101213A1 (en) COMBINATION OF A COMPOUND THAT ATTRACTS HARMFUL ARTHROPODS AND A NATURAL ENEMY
CL2017002931A1 (en) Method to increase the use of soy protein by salmonid fish.
AR118519A1 (en) STABILIZATION OF LIVE BACTERIA MOLLICUTES IN A LIQUID COMPOSITION